Structural characterization of CalO2: A putative orsellinic acid P450 oxidase in the calicheamicin biosynthetic pathway

Proteins: Structure, Function and Bioinformatics

Volumn 74, Issue 1, 2009, Pages 50-60

  McCoy, Jason G ^a   Johnson, Heather D ^a   Singh, Shanteri ^a   Bingman, Craig A ^a   Lei, In Kyoung ^a   Thorson, Jon S ^a   Phillips Jr , George N ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ACP; Biosynthesis; Natural product; Thioester; Type I PKS

Indexed keywords

ACYL CARRIER PROTEIN; BENZOIC ACID DERIVATIVE; CALICHEAMICIN; COENZYME A; GENOMIC DNA; NATURAL PRODUCT; ORSELLENIC ACID P450 OXIDASE; POLYKETIDE; POLYKETIDE SYNTHASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; IODINE; LIGAND; ORSELLINIC ACID; OXIDOREDUCTASE; RESORCINOL DERIVATIVE;

ARTICLE; BIOSYNTHESIS; CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ESCHERICHIA COLI; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; STREPTOMYCES LIVIDANS; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MICROMONOSPORA; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; STREPTOMYCES; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS);

ACYL CARRIER PROTEIN; ANIMALS; BACTERIAL PROTEINS; BIOSYNTHETIC PATHWAYS; COENZYME A; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; IODINE; LIGANDS; MICROMONOSPORA; OXIDOREDUCTASES; POLYKETIDE SYNTHASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RESORCINOLS; STREPTOMYCES;

EID: 58949097718     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22131     Document Type: Article

References (65)

1. Thorson JS, Sievers EL, Ahlert J, Shepard E, Whitwam RE, Onwueme KC, Ruppen M. Understanding and exploiting nature's chemical arsenal: the past, present and future of calicheamicin research. Curr Pharm Des 2000; 6:1841-1879.
2. Galm U, Hager MH, Van Lanen SG, Ju J, Thorson JS, Shen B. Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem Rev 2005; 105:739-758.
3. Biggins JB, Onwueme KC, Thorson JS. Resistance to enediyne antitumor antibiotics by CalC self-sacrifice. Science 2003; 301:1537-1541.
4. Singh S, Hager MH, Zhang C, Griffith BR, Lee MS, Hallenga K, Markley JL, Thorson JS. Structural insight into the self-sacrifice mechanism of enediyne resistance. ACS Chem Biol 2006; 1:451-460.
5. I: an antitumor antibiotic that cleaves double-stranded DNA site specifically. Science 1988; 240: 1198- 1201.
6. I and DNA: Molecular recognition process responsible for site-specificity. Science 989; 244:697-699.
7. I-DNA complex. J Mol Biol 1997; 265:187-201.
8. Walker S, Murnick J, Kahne D. Structural characterization of a calicheamicin DNA complex by NMR. J Am Chem Soc 1993; 115:7954-7961.
9. Wu AM, Senter PD. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 2005; 23:1137-1146.
10. Damle NK. Tumour-targeted chemotherapy with immunoconjugates of calicheamicin. Exp Opin Biol Ther 2004; 4:1445-1452.
11. Hamann PR. Monoclonal antibody-drug conjugates. Exp Opin on Therapeut Patents 2005; 15:1087-1103.
12. Zhang CS, Griffith BR, Fu Q, Albermann C, Fu X, Lee IK, Li LJ, Thorson JS. Exploiting the reversibility of natural product glycosyltransferase- catalyzed reactions. Science 2006; 313:1291-1294.
13. Kennedy DR, Gawron LS, Ju JH, Liu W, Shen B, Beerman TA. Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks. Cancer Res 2007; 67:773-781.
14. Shen B, Liu W, Nonaka K. Enediyne natural products: biosynthesis and prospect towards engineering novel antitumor agents. Curr Med Chem 2003; 10:2317-2325.
15. Jones GB, Fouad FS. Designed enediyne antitumor agents. Curr Pharm Des 2002; 8:2415-2440.
16. 1, an enediyne antitumor antibiotic. J Am Chem Soc 1993; 115:12340-12345.
17. Hensens OD, Giner JL, Goldberg IH. Biosynthesis of Ncs chrom-a, the chromophore of the antitumor antibiotic neocarzinostatin. J Am Chem Soc 1989; 111:3295-3299.
18. Tokiwa Y, Miyoshisaitoh M, Kobayashi H, Sunaga R, Konishi M, Oki T, Iwasaki S. Biosynthesis of dynemicin-a, a 3-ene-1,5-diyne antitumor antibiotic. J Am Chem Soc 1992; 114:4107-4110.
19. Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang KX, Fonstein L, Czisny A, Whitwam RE, Farnet CM, Thorson JS. The calicheamicin gene cluster and its iterative type I enediyne PKS. Science 2002; 297:1173-1176.
20. Liu W, Christenson SD, Standage S, Shen B. Biosynthesis of the enediyne antitumor antibiotic C-1027. Science 2002; 297:1170-1173.
21. Liu W, Ahlert J, Gao QJ, Wendt-Pienkowski E, Shen B, Thorson JS. Rapid PCR amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial classification model. Proc Natl Acad Sci USA 2003; 100:11959-11963.
22. Zazopoulos E, Huang KX, Staffa A, Liu W, Bachmann BO, Nonaka K, Ahlert J, Thorson JS, Shen B, Farnet CM. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 2003; 21:187-190.
23. Liu W, Nonaka K, Nie LP, Zhang J, Christenson SD, Bae J, Van Lanen SG, Zazopoulos E, Farnet CM, Yang CF, Shen B. The neocarzinostatin biosynthetic gene cluster from Streptomyces carzinostaticus ATCC 15944 involving two iterative type I polyketide synthases. Chem Biol 2005; 12:293-302.
24. Van Lanen SG, Oh TJ, Liu W, Wendt-Pienkowski E, Shen B. Characterization of the maduropeptin biosynthetic gene cluster from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis. J Am Chem Soc 2007; 129:13082-13094.
25. Gao Q, Thorson JS. The biosynthetic genes encoding for the production of the dynemicin enediyne core in Micromonospora chersina ATCC53710. FEMS Microbiol Lett 2008; 282:105-114.
26. Shen B. Polyketide biosynthesis beyond the type I. II and III polyketide synthase paradigms. Curr Opin Chem Biol 2003; 7:285-295.
27. Gaisser S, Trefzer A, Stockert S, Kirschning A, Bechthold A. Cloning of an avilamycin biosynthetic gene cluster from Streptomyces viridochromogenes Tü57. J Bacteriol 1997; 179:6271-6278.
28. Sthapit B, Oh TJ, Lamichhane R, Liou K, Lee HC, Kim CG, Sohng JK. Neocarzinostatin naphthoate synthase: an unique iterative type I PKS from neocarzinostatin producer Streptomyces carzinostaticus. FEBS Lett 2004; 566:201-206.
29. Jia XY, Tian ZH, Shao L, Qu XD, Zhao QF, Tang J, Tang GL, Liu W. Genetic characterization of the chlorothricin gene cluster as a model for spirotetronate antibiotic biosynthesis. Chem Biol 2006; 13:575-585.
30. Shao L, Qu XD, Jia XY, Zhao QF, Tian ZH, Wang M, Tang GL, Liu W. Cloning and characterization of a bacterial iterative type I polyketide synthase gene encoding the 6-methylsalicyclic acid synthase. Biochem Biophys Res Commun 2006; 345:133-139.
31. Zucai S, Huawei C, Walsh CT. Acyl-CoA hydrolysis by the high molecular weight protein 1 subunit of yersiniabactin synthetase: mutational evidence for a cascade of four acyl-enzyme intermediates during hydrolytic editing. Proc Natl Acad Sci USA 2000; 97:14188-14193.
32. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol A 1997; 276:307- 326.
33. Vagin A, Teplyakov A. MOLREP: an automated program for molecular replacement. J Appl Crystallogr 1997; 30:1022-1025.
34. Collaborative Computational Project N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994; 50 (Part 5):760-763.
35. Xiang JZ. Jackal version 1.5, 2002, New York.
36. Cowtan K. 'dm': an automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM. Newslett Protein Crystallogr 1994; 31:34-48.
37. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60 (Part 12, Part 1):2126-2132.
38. Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53 (Part 3):240-255.
39. Painter J, Merritt EA. TLSMD web server for the generation of multi-group TLS models. J Appl Crystallogr 2006; 39:109-111.
40. Painter J, Merritt EA. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 2006; 62 (Part 4):439-450.
41. DeLano WL. The PyMOL User's manual. Palo Alto: Delano Scientific: Delano Scientific; 2002.
42. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004; 20:45-50.
43. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy. Minimization and dynamics calculations. J Comp Chem 1983; 4: 187-217.
44. Mandell JG, Roberts VA, Pique ME, Kotlovyi V, Mitchell JC, Nelson E, Tsigelny I, Ten Eyck LF. Protein docking using continuum electrostatics and geometric fit. Protein Eng 2001; 14:105-113.
45. Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins 2003; 52:80-87.
46. Isin EM, Guengerich FP. Complex reactions catalyzed by cytochrome P450 enzymes. Biochim Biophys Acta 2007; 1770:314-329.
47. Pylypenko O, Schlichting I. Structural aspects of ligand binding to and electron transfer in bacterial and fungal p450s. Annu Rev Biochem 2004; 73:991-1018.
48. Lewis DFV, Wiseman A. A selective review of bacterial forms of cytochrome P450 enzymes. Enzyme Microbial Technol 2005; 36:377-384.
49. Urlacher VB, Eiben S. Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol 2006; 24:324-330.
50. Wade RC, Winn PJ, Schlichting I, Sudarko. A survey of active site access channels in cytochromes P450. J Inorg Biochem 2004; 98:1175-1182.
51. Cojocaru V, Winn PJ, Wade RC. The ins and outs of cytochrome P450s. Biochim Biophys Acta 2007; 1770:390-401.
52. Nagano S, Poulos TL. Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism. J Biol Chem 2005; 280:31659-31663.
53. Cupp-Vickery J, Anderson R, Hatziris Z. Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity. Proc Natl Acad Sci USA 2000; 97:3050-3055.
54. Oshima R, Fushinobu S, Su F, Zhang L, Takaya N, Shoun H. Structural evidence for direct hydride transfer from NADH to cytochrome P450nor. J Mol Biol 2004; 342:207-217.
55. Makino M, Sugimoto H, Shiro Y, Asamizu S, Onaka H, Nagano S. Crystal structures and catalytic mechanism of cytochrome P450 StaP that produces the indolocarbazole skeleton. Proc Natl Acad Sci USA 2007; 104:11591-11596.
56. Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM. The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae. J Biol Chem 2006; 281:26289-26297.
57. Stok JE, De Voss J. Expression, purification, and characterization of BioI: a carbon-carbon bond cleaving cytochrome P450 involved in biotin biosynthesis in Bacillus subtilis. Arch Biochem Biophys 2000; 384:351-360.
58. Eustaquio AS, Luft T, Wang ZX, Gust B, Chater KF, Li SM, Heide L. Novobiocin biosynthesis: inactivation of the putative regulatory gene novE and heterologous expression of genes involved in aminocoumarin ring formation. Arch Microbiol 2003; 180:25-32.
59. Chen H, Hubbard BK, O'Connor SE, Walsh CT. Formation of (β- hydroxy histidine in the biosynthesis of nikkomycin antibiotics. Chem Biol 2002; 9:103-112.
60. Chen H, Walsh CT. Coumarin formation in novobiocin biosynthesis: (β-hydroxylation of the aminoacyl enzyme tyrosyl-S-NovH by a cytochrome P450 NovI. Chem Biol 2001; 8:301-312.
61. Zerbe K, Woithe K, Li DB, Vitali F, Bigler L, Robinson JA. An oxi-dative phenol coupling reaction catalyzed by oxyB, a cytochrome P450 from the vancomycin-producing microorganism. Angew Chem Int Ed 2004; 43:6709-6713.
62. Zhang YM, Rao MS, Heath RJ, Price AC, Olson AJ, Rock CO, White SW. Identification and analysis of the acyl carrier protein (ACP) docking site on (β-ketoacyl-ACP synthase III. J Biol Chem 2001; 276:8231-8238.
63. Parris KD, Lin L, Tam A, Mathew R, Hixon J, Stahl M, Fritz CC, Seehra J, Somers WS. Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites. Structure 2000; 8:883-895.
64. Rafi S, Novichenok P, Kolappan S, Zhang X, Stratton CF, Rawat R, Kisker C, Simmerling C, Tonge PJ. Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli. J Biol Chem 2006; 281:39285-39293.
65. Zhang YM, Wu B, Zheng J, Rock CO. Key residues responsible for acyl carrier protein and beta-ketoacyl-acyl carrier protein reductase (FabG) interaction. J Biol Chem 2003; 278:52935-52943.